secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001459839-24-000039
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE reports Q1 revenue $37.9M (+16% YoY); raises FY2024 guidance to $164-166M
--------------------------------------------------------------------------------

- Worldwide revenue $37.9M, up 16% YoY; U.S. revenue $35.4M, also up 16%.
- Gross margin ~79%, down from ~82% due to product and procedure mix.
- Net loss $10.9M ($0.27 diluted EPS) vs $11.1M ($0.32) in Q1 2023; adjusted EBITDA loss $4.0M.
- FY2024 revenue guidance raised to $164-166M (18-20% growth) from $162-165M.
- Surpassed 100,000 procedures; introduced smaller diameter iFuse Bedrock Granite implant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000039/0001459839-24-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000039/sibn-20240506.htm
  HTML page:      https://secwatch.observer/filing/0001459839-24-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer